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RESEARCH ARTICLE
Oral vitamin A supplementation of porcine 
epidemic diarrhea virus infected gilts enhances 
IgA and lactogenic immune protection 
of nursing piglets
Stephanie N. Langel1, Francine Chimelo Paim1, Moyasar A. Alhamo1, Kelly M. Lager2, Anastasia N. Vlasova1* 
and Linda J. Saif1* 
Abstract 
Vitamin A (VA) has pleiotropic effects on the immune system and is critical for mucosal immune function and intesti-
nal lymphocyte trafficking. We hypothesized that oral VA supplementation of porcine epidemic diarrhea virus (PEDV)-
infected pregnant gilts would enhance the gut-mammary gland-secretory IgA axis to boost lactogenic immunity 
and passive protection of nursing piglets against PEDV challenge. Gilts received daily oral retinyl acetate (30 000 IU) 
starting at gestation day 76 throughout lactation. At 3–4 weeks pre-partum, VA-supplemented (PEDV + VA) and 
non-supplemented (PEDV) gilts were PEDV or mock inoculated (mock + VA and mock, respectively). PEDV + VA gilts 
had decreased mean PEDV RNA shedding titers and diarrhea scores. To determine if lactogenic immunity correlated 
with protection, all piglets were PEDV-challenged at 3–5 days post-partum. The survival rate of PEDV + VA litters was 
74.2% compared with 55.9% in PEDV litters. Mock and mock + VA litter survival rates were 5.7% and 8.3%, respectively. 
PEDV + VA gilts had increased PEDV IgA antibody secreting cells and PEDV IgA antibodies in serum pre-partum and 
 IgA+β7+ (gut homing) cells in milk post piglet challenge compared with PEDV gilts. Our findings suggest that oral VA 
supplementation may act as an adjuvant during pregnancy, enhancing maternal IgA and lactogenic immune protec-
tion in nursing piglets.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Diarrheal disease represents a major global health bur-
den and is the leading cause of morbidity and mortality in 
young humans and animals alike [1, 2]. In young animals, 
diarrheal disease accounts for an estimated multi-million 
dollar loss annually to the livestock industry due to mor-
tality, reduced weight gain, treatment costs and trade 
sanctions on exporting animal products from infected 
countries [3, 4]. Passive lactogenic immunity that 
provides protective IgG in colostrum and a continuous 
supply of secretory IgA (sIgA) in milk plays a significant 
role in conferring protection against enteric pathogens in 
neonates [5]. For example higher pathogen-specific IgA 
antibody (Ab) titers in milk are associated with lower 
incidence of enteric disease in pigs and children [6–9]. 
Additionally, boosting the maternal immune response 
may have beneficial consequences for the mother, provid-
ing protection against disease during pregnancy and lac-
tation. Enhancing immunity by maternal vaccination has 
the potential to provide a dual benefit in immune protec-
tion for the mother–neonatal dyad.
Porcine epidemic diarrhea virus (PEDV) is an alphac-
oronavirus that causes acute diarrhea, dehydration and 
80–100% mortality in neonatal piglets [2, 10]. In adult 
pigs, PEDV causes watery diarrhea, depression and 
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anorexia as well as agalactia and reduced reproductive 
performance [2, 11]. Due to the high virulence of PEDV 
and the naïve, immature immune system of neonatal pig-
lets, passive lactogenic immunity to PEDV induced via 
the gut-mammary gland (MG)-sIgA axis during preg-
nancy and lactation remains the most promising and 
effective way to protect nursing piglets against PEDV-
induced disease [8, 12–15]. Providing sufficient PEDV-
specific lactogenic immunity is dependent on trafficking 
of IgA antibody secreting cells (ASCs) from the intes-
tine to the MG and accumulation of sIgA Abs in milk 
[7, 8, 13, 14, 16]. However, little is known regarding the 
anti-viral humoral immune response during pregnancy 
and the level of lactogenic immune protection gener-
ated after induction of the gut-MG-sIgA axis is variable. 
Indeed, our lab demonstrated that third trimester PEDV-
infected gilts provided insufficient passive lactogenic 
immune protection to PEDV-challenged nursing piglets 
compared with second or first trimester PEDV-infected 
gilts [16]. Therefore, identifying cost effective strategies 
to stimulate and enhance trafficking of PEDV IgA ASCs 
to the MG and accumulation of PEDV sIgA Abs in milk 
in a pregnant swine model is critical for development of 
maternal vaccines and therapeutics that improve mater-
nal and lactogenic immunity and neonatal health.
Retinoic acid (RA) is a vitamin A (VA) metabolite with 
pleiotropic effects on the immune system [17, 18]. For 
example, VA deficient (VAD) individuals with serum 
retinol levels at 0.70 µmol/L or below are more suscepti-
ble to some enteric and respiratory diseases, with young 
children at the highest risk [19, 20]. Specifically, VA is 
required for the enhancement and regulation of immune 
responses and cellular trafficking in the gut. Lamina 
propria (LP)  CD103+ dendritic cells (DCs) synthesize 
RA through expression of retinal dehydrogenases (i.e. 
Aldh1a1/2) [21]. Synergistically with locally produced 
cytokines,  CD103+ LP DCs upregulate mucosal traffick-
ing adhesion molecules, integrin α4β7 and chemokine 
CC receptor (CCR)9 expression on B and T lympho-
cytes after interaction in the Peyer’s Patches or mes-
enteric lymph node (MLN) [22–24]. For example, VAD 
mice had significantly decreased α4β7+ memory T cells 
in lymphoid organs and T cells in the LP [24]. Addition-
ally, VAD alters cytokine responses during infection by 
skewing towards an increased T-helper cell type-1 (Th1) 
cytokine response in infants and mice [25, 26]. Treat-
ment of T cells with 10  nM RA in  vitro resulted in a 
shift toward Th2 cytokine responses [26] promoting an 
immunoregulatory environment. Therefore, even sub-
clinical deficiencies in VA may negatively impact mucosal 
lymphocyte trafficking and gut homeostasis during 
pregnancy.
Also relevant to mucosal immune responses is the 
role of RA in B cell differentiation and IgA production. 
Using a gnotobiotic pig model, our lab demonstrated that 
subclinical VAD piglets had decreased frequencies of 
 CD103+ LP DCs, resulting in decreased adaptive immune 
responses to human rotavirus (HRV) and prolonged diar-
rhea [27, 28]. VAD gnotobiotic piglets vaccinated with 
attenuated HRV demonstrated higher diarrhea severity 
post HRV challenge compared with vaccinated VA suffi-
cient piglets. This coincided with lower serum IgA HRV 
Ab titers and significantly decreased intestinal IgA ASCs 
post-challenge suggesting a compromised anamnestic 
immune response [28, 29]. However, these parameters 
and the impact of VA supplementation during pregnancy 
on the gut-MG-sIgA axis and passive neonatal immunity 
are largely undefined. Therefore, we hypothesized that 
oral VA supplementation of PEDV-infected pregnant 
gilts would enhance trafficking of IgA ASCs from the gut 
to the MG leading to increased accumulation of sIgA Abs 
in milk and passive lactogenic protection of PEDV-chal-
lenged nursing piglets.
The risk of subclinical and clinical VAD increases with 
gestational age due to accelerated growth of the fetus 
and the physiological increase of blood volume in swine 
and humans [27, 30]. Dietary VA recommendations 
given for swine [31] are represented by physiologically-
based mathematical models developed for relatively 
disease-free environments. Therefore, it is likely that 
the dietary VA required during pregnancy to efficiently 
stimulate the gut-MG-sIgA axis and provide sufficient 
lactogenic immune protection to neonates during an 
enteric viral infection is higher than current dietary rec-
ommendations. To investigate the impact of daily oral VA 
supplementation during gestation and lactation, we sup-
plemented gilts with non-teratogenic, yet physiologically 
relevant levels of oral retinyl acetate [30 000 international 
units (IU)] daily starting at the beginning of the third 
trimester and lasting throughout lactation. We dem-
onstrated that daily oral VA supplementation in PEDV-
infected gilts decreased diarrhea, increased the numbers 
of PEDV IgA ASCs and PEDV IgA Abs in serum pre-
partum and IgA immunoglobulin secreting cells (IgSCs) 
and  IgA+β7+ cells in milk post piglet challenge, providing 
greater lactogenic immune protection to neonatal nurs-
ing piglets.
Materials and methods
Virus
The wild-type PC22A strain of PEDV was used for gilt 
infection and piglet challenge at a dose of 1 × 105 plaque 
forming units diluted in Minimal Essential Media [MEM 
(Life Technologies, Carlsbad, CA, USA)]. Briefly, PC22A 
was isolated and cultured in Vero cells as described 
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previously [32, 33]. Cells were grown in growth medium 
containing Dulbecco’s Modified Eagle’s Medium [DMEM 
(Life Technologies, Carlsbad, CA, USA)] supplemented 
with 5% fetal bovine serum (Life Technologies, Carlsbad, 
CA, USA) and 1% antibiotic–antimycotic (Life Tech-
nologies, Carlsbad, CA, USA). Virus was grown in Vero 
cells in maintenance medium containing DMEM sup-
plemented with 10  μg/mL trypsin (Life Technologies, 
Carlsbad, CA), 0.3% tryptose phosphate broth (Sigma 
Aldrich, St. Louis, MO, USA), and 1% antibiotic–antimy-
cotic. Cells were kept in a humidified incubator at 37 °C 
and 5%  CO2. PC22A was passaged three times in Vero 
cells before passaging once for generation of inoculum in 
a gnotobiotic pig. The virulence of pig passaged PC22A 
was confirmed in adult and neonatal pigs as described 
previously [13, 34, 35]. Cell-culture adapted PC22A was 
used as a positive control in the virus neutralization (VN) 
Ab assay.
Experimental design
All animal experiments were approved by the Institu-
tional Animal Care and Use Committee at The Ohio 
State University. All methods were carried out in accord-
ance with approved protocol (2015A00000071) and rel-
evant regulations and pigs were maintained, sampled, 
and euthanized humanely. First parity PEDV and trans-
missible gastroenteritis virus (TGEV) seronegative preg-
nant gilts (Landrace × Yorkshire × Duroc cross-bred) 
arrived at our facilities from either The Ohio State Uni-
versity swine center facility or a commercial swine herd 
by gestation day (GD) 70 and housed individually in an 
open pen during gestation and the majority of lacta-
tion. Gilts were placed in farrowing crates 3–5  days 
prior to expected farrowing and 3–5  days post-partum 
to ensure safe delivery and interaction with piglets. Arti-
ficial light was regulated by a 12:12 light/dark timer. 
However, natural light also entered the animal rooms 
from nearby windows. Gilts were randomly assigned to 
one of four treatment groups: (1) MEM-infected (mock) 
(n = 4); (2) MEM-infected + daily oral VA supplemented 
(mock + VA) (n = 4); (3) third trimester [GD 96–97 
(~18  days pre-partum)] PEDV-infected (PEDV) (n = 6); 
and (4) third trimester PEDV-infected + daily oral VA 
supplemented (PEDV + VA) (n = 5). VA-supplemented 
gilts orally received 30  000  IU/day of retinyl acetate 
from GD 76 throughout lactation (Figure 1A). Consider-
ing the circadian nature of trafficking lymphocytes [36, 
37] retinyl acetate was supplemented two times per day 
(15 000 IU at 0900 h and 15 000 IU at 1700 h). Gilt fecal 
samples were collected, and clinical signs observed on 
post-PEDV infection day (PID) 0–15. Fecal consistency 
was scored as follows: 0, solid; 1, pasty; 2, semi-liquid; 
3, liquid, respectively. A fecal consistency score of > 1 
was considered as diarrhea [13, 38]. Blood samples were 
taken on PID 0, 6–8 and 13–17 for serum and mononu-
clear cell (MNC) isolation (Figure 1A). All gilts naturally 
farrowed in our facilities at GD 114 (± 3) and colostrum 
was collected within 12 h of parturition. All piglets were 
allowed to suckle naturally after birth and were kept with 
their mothers throughout lactation. Piglets were orally 
PEDV-challenged at 3–5 days of age (Figure 1B). Gilt and 
piglet serum was collected on post piglet challenge day 
(PCD) 0, 5–9, 12–17 and 21–29. All colostrum and milk 
samples were collected after administration of 2 cc oxy-
tocin intramuscularly (IM) at post-partum day (PPD) 0, 
3–5, 8–14 and 15–22 (Figure 1B). Gilt MG biopsies were 
collected at GD 104–114 and PPD 8–14. Piglet fecal sam-
ples were collected, and clinical signs and body weights 
recorded daily on PCD 0–7 and every other day through 
PCD 15. All animals were euthanized at PCD 21–29. Gilt 
blood, ileum, MG, MLN and spleen tissues were col-
lected for MNC isolation. Piglet blood was collected, and 
the serum separated for immunologic assays.
Serum VA concentrations
Serum samples were collected as reported previously [27] 
and submitted to the Diagnostic Center for Population 
and Animal Health (Michigan State University, Lansing, 
MI, USA) for quantitative VA concentrations by HPLC.
PEDV RNA quantification by real‑time quantitative 
polymerase chain reaction (RT‑qPCR)
To determine PEDV RNA shedding titers, two rectal 
swabs were suspended in 4 mL MEM as described pre-
viously [35]. Viral RNA was extracted from 50  μL of 
fecal supernatants following centrifugation (2000  ×  g 
for 30 min at 4  °C) using the MagMAX Viral RNA Iso-
lation Kit (Applied Biosystems, Foster City, CA, USA) 
according to the manufacturer’s instructions. Titers of 
viral RNA shed in feces were determined by TaqMan RT-
qPCR using the Onestep RT-PCR Kit (QIAGEN, Valen-
cia, CA, USA) as described previously [35]. The detection 
limit was 10 copies per 20 µL of reaction, corresponding 
to 4.8  log10 copies/mL of original fecal samples.
Isolation of MNCs from blood, spleen, MG, MLN and ileum
Blood, spleen, MG, MLN and ileum were collected 
aseptically at euthanasia and processed for MNC isola-
tion as described previously [16, 39]. The isolated cells 
were resuspended in enriched RPMI [E-RPMI (Roswell 
Park Memorial Institute)] medium containing 8% fetal 
bovine serum, 2  mM l-glutamine, 1  mM sodium pyru-
vate, 0.1  mM nonessential amino acids, 20  mM HEPES 
(N-2-hydroxy-ethylpiperazine-N-2-ethanesulfonic 
acid), and 1% antibiotic–antimycotic (Life Technologies, 
Carlsbad, CA, USA) and used for assays. The viability of 
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MNCs was determined by trypan blue exclusion. Briefly, 
MNCs were diluted twofold in 0.4% trypan blue before 
visualizing using an automated cell counter (Cellometer, 
Nexcelom, Lawrence, MA, USA). The viability (%) was 
calculated as [1.00 − (number of blue cells/number of 
total cells)] × 100.
Detection of cytokines in serum by ELISA
Serum samples from PEDV and PEDV + VA gilts were 
processed and analyzed for proinflammatory [tumor 
necrosis factor (TNF)-α, interleukin (IL)-6], innate 
[interferon (IFN)-α] and Th1 (IL-12, IFN-γ), Th2 (IL-4), 
Th17 (IL-22) and T regulatory/anti-inflammatory [IL-10 
and transforming growth factor (TGF)-β] cytokines as 
described previously [16].
Colostrum/milk processing for whey and isolation of MNCs
Colostrum/milk was collected aseptically after gilts 
were given 2 cc oxytocin (VetOne, Boise, ID, USA) IM 
to facilitate collection of mammary secretions. Sam-
ples were filtered through a 70 μm pore filter and cen-
trifuged at 1800 × g for 30 min at 4 °C to separate fat, 
skim milk and cell pellet portions. Fat was removed 
utilizing sterile plain-tipped applicators (Fisher Sci-
entific, Hampton, NH, USA). Skim milk was collected 
and centrifuged at 28 000 × g for 1 h at 4 °C to separate 
the whey that was then stored at −20  °C until tested. 
Figure 1 Serum VA concentrations decreased immediately prior to parturition in gestating gilts. A Schematic diagram of the experimental 
design showing gilt PEDV infection and sample time points at post-infection day (PID) 0 [gestation day (GD) 96–97], 6–8 (GD 102–105) and 13–17 
(GD 109–114) and B piglet PEDV challenge at 3–5 post-partum day (PPD) and sample time points at PPD 3–5 [PCD (post-challenge day) 0], PPD 
8–14 (PCD 5–9), PPD 15–22 (PCD 12–17) and PPD 24–34 (PCD 21–29). C Pooled serum VA concentrations (ng/mL) in gilts pre and post-partum. 
Statistical analysis was performed using the two-way ANOVA with repeated measures and Bonferroni’s correction for multiple comparisons. Data 
are mean ± SEM.
Page 5 of 16Langel et al. Vet Res          (2019) 50:101 
Colostrum and milk MNCs were isolated as described 
previously [16]. The viability of MNCs was determined 
by trypan blue exclusion.
PEDV plaque reduction VN assay
A plaque reduction VN assay was performed as 
described previously [16]. Plaques were counted and 
the VN titers were determined by taking the reciprocal 
of the highest dilution of a serum/whey sample show-
ing an 80% reduction in the number of plaques com-
pared with seronegative control serum/whey. Samples 
negative at a dilution of 1:16 were assigned a titer of 1:2 
for the calculation of geometric mean titers (GMTs).
PEDV whole virus Ab ELISA
A PEDV whole virus Ab ELISA was performed as 
described previously [16]. The ELISA Ab titer was 
expressed as the reciprocal of the highest dilution 
that had a corrected A450 value (sample absorbance in 
the virus-coated well minus sample absorbance in the 
mock antigen-coated well) greater than the cut-off 
value (mean corrected A450 value of negative controls 
plus 3 standard deviations). Samples negative at a dilu-
tion of 1:4 were assigned a titer of 1:2 for the calcula-
tion of GMTs.
Total and PEDV Enzyme‑Linked Immunosorbent Spot 
(ELISPOT)
Enumeration of total IgSCs and PEDV-specific ASCs 
was performed as described previously [16, 39]. Counts 
were averaged from duplicate wells and expressed rela-
tive to 5 × 105 MNC.
Histologic analysis and evaluation of PEDV  Ab+ cells 
in the MG
PEDV  Ab+ cells in the MG were analyzed as described 
previously [16]. Microscopic images (300× magnifica-
tion) were obtained using a fluorescence microscope 
(Olympus IX70-S1F2). Mean numbers of PEDV  Ab+ 
cells were evaluated by measuring at least 3–6 differ-
ent tissue areas at 300× magnification for each sample 
time point (GD 104–114 and PCD 5–9) from mock, 
mock + VA, PEDV and PEDV + VA gilts.
Flow cytometry to assess B/T lymphocytes and homing 
marker integrin and receptor frequencies
Procedures for flow cytometry staining (including buff-
ers used) were performed as described previously with 
minor modifications [16, 27]. Briefly, 100 μL of MNCs 
at 1 × 107 cells/mL were stained with anti-porcine 
CD21-PE (clone BB6-11C9.6, Southern Biotech, 1:50) 
and anti-porcine CD2 (clone MSA4, VMRD, 1:50) 
monoclonal Abs to determine B cell subsets [40]. To 
determine expression of α4 integrin and β7 integrin, 
cells were stained with porcine cross-reactive anti-
human α4 integrin (clone HP2/1, Abcam, Cambridge, 
MA, 1:100) and anti-mouse β7 integrin (clone FIB27, 
BD Biosciences, 1:50) monoclonal Abs. Addition-
ally, to determine expression of IgA, cells were stained 
with anti-porcine IgA (clone K61 1B4, Bio-Rad, 1:50) 
monoclonal Ab. After washing, cells were stained with 
appropriate secondary antibodies. For intracellular 
CD79β, stained cells were permeabilized with Cyto-
fix/Cytoperm (BD Biosciences), washed with Perm/
Wash Buffer (BD Biosciences) and stained with por-
cine cross-reactive anti-mouse CD79β-FITC Ab (clone 
AT1072, Bio-Rad, 1:50) monoclonal Ab. Additionally, 
 CD4+ (anti-porcine CD4, clone 74-12-4, Southern Bio-
tech, 1:50) and  CD8+ (anti-porcine CD8, clone 76-2-11, 
Southern Biotech, 1:50) T cells were assessed within the 
 CD3+ (anti-porcine CD3, clone PPT3, Southern Bio-
tech, 1:100) MNC population (T lymphocytes). Appro-
priate isotype matched control Abs were included. 
Acquisition of 50  000 events and analyses were done 
using the Accuri C6 flow cytometer (BD Biosciences, 
San Jose, CA, USA). All cells were first gated for sin-
glets (FSC-H vs. FSC-A) and MNCs (SSC-A vs. FSC-A). 
To determine B cell subsets, MNC populations were 
analyzed by CD79β expression. α4+β7+ and  IgA+β7+ 
MNCs were determined within the CD79β+ population 
as described previously [16].
Statistics
Two-way analysis of variance (ANOVA-general linear 
model), followed by Bonferroni’s post-test, was used to 
compare serum VA concentrations, PEDV RNA shedding 
titers, fecal consistency scores, mean concentrations of 
serum cytokines, frequencies of blood MNC populations 
in flow cytometry, PEDV IgA and IgG ASCs, log-trans-
formed PEDV IgA, IgG and VN Ab titers, normalized 
weights and PEDV  Ab+ cells in the MG. The frequen-
cies of cell populations and PEDV IgA and IgG ASCs in 
milk and ileum were compared among groups with the 
Mann–Whitney (nonparametric) t test. The log-rank 
(Mantel-Cox) test was used for comparison of survival 
curves amongst treatment groups. Statistical significance 
was assessed at P ≤ 0.05 for all comparisons. Assays were 
run by investigators blinded to sample and treatment 
identification prior to analysis. All statistical analyses and 
random number generation for treatment randomization 
were performed with GraphPad Prism 5 (GraphPad Soft-
ware, Inc., CA, USA).
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Results
Serum VA concentrations decreased in gilts regardless 
of treatment, immediately prior to parturition
Oral VA supplementation in third trimester gilts did not 
significantly alter mean serum VA concentrations. How-
ever, when gilts (± VA) were pooled, there was a trend for 
decreased mean serum VA concentrations immediately 
prior to parturition (Figure 1C).
PEDV RNA shedding titers and PEDV‑induced diarrhea 
were lower in PEDV + VA gilts
Mean PEDV RNA shedding titers were consistently 
numerically lower (PID 4–9) and there was a more rapid 
rate of decrease in mean PEDV RNA shedding titers at 
PID 12–14 in PEDV + VA compared with PEDV gilts 
(Figure 2A). Additionally, mean fecal consistency scores 
at PID 3 and 5 were significantly lower in PEDV + VA 
compared with PEDV gilts (Figure 2B).
Oral VA supplementation modulated cytokine immune 
parameters during PEDV infection
There was a trend for higher IFN-α and IFN-γ, type I and 
II interferons, respectively, at PID 13–17 in PEDV but not 
PEDV + VA gilts while immunoregulatory cytokine IL-10 
increased numerically at PID 6–8 in PEDV + VA com-
pared with PEDV gilts (Additional file  1). Additionally, 
there was a trend for increased mean concentrations of 
IL-22, a cytokine that promotes tissue regeneration and 
repair in the gut [41] at PID 6–8 in PEDV + VA com-
pared with PEDV gilts (Additional file 1). No other trends 
were observed for serum concentrations of TNF-α, IL-6, 
IL-12, IL-4 or TGF-β (Additional file 1).
Oral VA significantly increased pre‑partum levels 
of circulating PEDV IgA ASCs and Abs and  IgA+β7+ MNCs
The mean number of circulating PEDV IgA ASCs was 
significantly higher at PID 13–17 in PEDV + VA com-
pared with PEDV gilts (Figures  3A and B). PEDV + VA 
gilts had significantly higher mean frequencies of circu-
lating α4+β7+ B cells (normalized to PID 0) compared 
with mock gilts at PID 13–17 (Figure  3C). PEDV + VA 
gilts also had significantly higher mean frequencies of 
circulating  IgA+β7+ MNCs (normalized to PID 0) at PID 
6–8 compared with mock and PEDV gilts (Figure  3D). 
Whereas no significant differences were seen in pre-
partum levels of circulating PEDV IgG ASCs, IgG Abs or 
VN Abs post PEDV infection (Additional file  2), PEDV 
IgA Ab titers were significantly higher at PID 6–8 in 
PEDV + VA compared with PEDV gilts (Figure 3E).
PEDV + VA litters had decreased mortality and morbidity
Piglets were PEDV-challenged at 3–5  days of age to 
determine the impact of maternal VA supplementa-
tion on lactogenic immunity and piglet morbidity and 
Figure 2 Daily oral VA supplementation significantly decreased diarrhea in PEDV infected gilts. A Virus shedding was determined by 
real-time quantitative polymerase chain reaction (RT-qPCR) and expressed as  log10 copies/mL. B Diarrhea was determined by fecal consistency 
score > 1 (fecal consistency was scored as follows: 0, normal; 1, pasty/semiliquid; 2, liquid; 3, watery). Different alphabetical letters indicate significant 
differences among treatment groups (mean ± SEM). Statistical analysis was performed using the two-way ANOVA with repeated measures and 
Bonferroni’s correction for multiple comparisons. *P < 0.05.
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mortality. The survival rate of PEDV + VA litters was 
74.2% compared with 55.9% in PEDV litters. Mock 
and mock + VA piglet survival rates were 5.7 and 8.3%, 
respectively (Figure  4A). Comparison of piglet weight 
gains revealed that PEDV + VA litters had signifi-
cantly higher normalized weights at PCD 9 compared 
with PEDV litters (Figure  4B). Additionally, mock lit-
ters (± VA) were stunted (decreased or no weight gain) 
from PCD 1–7 and had the lowest normalized weights 
throughout the study. Although normalized mean 
weights at PID 15 were higher in mock + VA com-
pared with mock piglets, these data represent only two 
surviving piglets in each respective treatment group. 
PEDV + VA piglets had significantly decreased PEDV 
RNA shedding titers at PCD 2 and lower and delayed 
mean peak shedding titers compared with PEDV piglets 
(Figure  4C). While not significantly different between 
piglets of PEDV + VA and PEDV gilts, fecal consist-
ency scores decreased at a faster rate at PCD 7–15 in 
PEDV + VA compared with PEDV litters (Figure  4D). 
VA supplementation in mock gilts did not result in 
decreased morbidity or mortality in PEDV-challenged 
piglets.
Oral VA supplementation increased milk PEDV IgA ASCs, 
total IgA IgSCs, and  IgA+β7+ cells post piglet challenge
To determine the impact of maternal VA supplementa-
tion on lactogenic immunity, adaptive immune param-
eters were measured in colostrum and milk. Mean 
PEDV IgA ASCs in milk were significantly higher at 
PPD 8–14 (PCD 5–9) in PEDV + VA compared with 
PEDV gilts (Figure  5A). Additionally, mean milk IgA 
Figure 3 Circulating PEDV specific IgA ASCs were significantly increased in PEDV + VA gilts pre‑partum. A, B Peripheral blood MNCs 
(PBMCs) were isolated and added to PEDV ELISPOT plates to determine the PEDV specific IgA ASCs. C PBMCs were isolated and analyzed for 
frequencies of α4+β7+ B cells and D  IgA+β7+ MNCs by flow cytometry E PEDV IgA Abs were determined by ELISA. Asterisks indicate significant 
differences among treatment groups at the same time point (mean ± SEM). Frequencies of α4+β7+ B cells and  IgA+β7+ MNCs were normalized 
by dividing by post-challenge day (PCD) 0 frequencies. Statistical analysis was performed using the two-way ANOVA with repeated measures and 
Bonferroni’s correction for multiple comparisons. *P < 0.05 **P < 0.01 ***P < 0.001.
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IgSCs at PPD 8–14 (PCD 5–9) were significantly higher 
in PEDV + VA compared with PEDV gilts at the same 
time point (Figures 5B and C). Milk MNCs from PEDV 
(± VA) gilts were isolated and stained for expression of 
IgA and mucosal homing receptor β7 integrin. Mean 
milk  IgA+β7+ cell frequencies were numerically higher 
(P = 0.06) in PEDV + VA compared with PEDV gilts 
at PPD 8–14 (PCD 5–9) (Figure  5D). Due to the high 
mortality rate of mock (± VA) litters, the MGs of mock 
gilts regressed rapidly [42]. Therefore, there was not 
enough milk available from mock gilts to isolate MNCs 
at PPD 8–14 (PCD 5–9). Mean PEDV IgA and VN Ab 
titers were numerically higher [PPD 8–14 (PCD 5–9) 
for IgA Abs; PPD 3–5 (PCD 0) and PPD 8–14 (PCD 
5–9) for PEDV VN Abs] in PEDV + VA compared with 
PEDV gilts and significantly higher in PEDV (± VA) 
compared with mock (± VA) gilts at similar time points 
(Figures 5E and F). This is consistent with our hypoth-
esis that IgA ASC in milk may play a role in lactogenic 
immune protection in neonatal piglets against PEDV 
challenge.
Figure 4 PEDV + VA litters had increased survival rates and decreased PEDV RNA shedding titers. A Kaplan–Meier survival curve of 
mock, mock + VA, PEDV and PEDV + VA litters at post-challenge day (PCD) 0–14. B Normalized weight gain of litters at PCD 0–15. Weights were 
normalized by dividing the daily weight (lbs) by PCD 0 weight (lbs). C Diarrhea was determined by fecal consistency score > 1 (fecal consistency 
was scored as follows: 0, normal; 1, pasty/semiliquid; 2, liquid; 3, watery). D Virus shedding was determined by real time quantitative polymerase 
chain reaction (RT-qPCR) and expressed as  log10 copies/mL. Piglet diarrhea scores and viral shedding were measured at PCD 1–7, 9, 11, 13, and 
15. Different alphabetical letters indicate significant differences among treatment groups at the same time point (mean ± SEM). Statistical analysis 
was performed using the log-rank (Mantel-Cox) test (A) or the two-way ANOVA with repeated measures and Bonferroni’s correction for multiple 
comparisons (B–D).
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PEDV  Ab+ cells in the MG increased post piglet PEDV 
challenge
There were no differences in mean PEDV  Ab+ cells per 
microscopic field at gilt GD 104–114 in PEDV + VA 
compared with PEDV gilts (Figures  6A and B). While 
there were no PEDV  Ab+ cells in the MG of mock or 
mock + VA gilts at GD 104–114, PEDV + VA and PEDV 
gilts had significantly higher numbers of PEDV  Ab+ 
cells per microscopic field (300×) in the MG at PCD 
5–9 compared with mock gilts (± VA) (Figures 6A and 
B).
PEDV exposure post piglet challenge affected circulating 
ASC and Ab responses in gilts and piglets
Circulating levels of PEDV IgA ASCs, PEDV IgA Abs and 
PEDV VN Abs were measured at PCD 0, 5–9, 12–17 and 
21–29 in gilts and piglets. Circulating mean numbers of 
PEDV IgA ASCs in PEDV + VA gilts were significantly 
higher at PCD 5–9 compared with mock (± VA) gilts 
(Figure  7A). However, mock + VA gilts had significantly 
higher circulating PEDV IgA ASCs compared with PEDV 
gilts at PPD 12–17 (Figure  7A). Mean PEDV IgA Ab 
titers were numerically higher at PCD 12–17 and 21–29 
in PEDV + VA compared with PEDV gilts (Figure  7B). 
PEDV gilts (± VA) had significantly elevated levels of 
PEDV IgA ASCs and Abs and VN Abs at PCD 5–9 com-
pared with mock gilts (± VA) demonstrating an anamnes-
tic response in PEDV gilts (± VA) (Figures 7A–C). Piglet 
mean PEDV IgA Ab titers were higher in PEDV + VA 
compared with PEDV (numerically) and mock (signifi-
cantly) litters from PCD 0–17 (Figure 7D). Additionally, 
piglet serum mean PEDV IgA Ab titers increased in all 
treatment groups post piglet challenge (Figure 7D).
Figure 5 PEDV + VA gilts had elevated levels of milk PEDV specific IgA ASCs and Abs, and IgA IgSCS. A Milk MNCs were isolated and added 
to PEDV specific and B, C total ELISPOT plates to determine the PEDV specific IgA ASCs and IgA IgSCs. D Milk MNCs were isolated and analyzed 
for frequencies of  IgA+β7+ B cells by flow cytometry E PEDV IgA and F virus neutralizing (VN) Abs were determined by VN Ab assay, respectively. 
Asterisks indicate significant differences among treatment groups at the same time point (mean ± SEM). Statistical analysis was performed using 
a Mann–Whitney t-test (B–D) or two-way ANOVA with repeated measures and Bonferroni’s correction for multiple comparisons (A, E, F). *P < 0.05 
***P < 0.001.
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IgA and IgG ASCs and ileal α4+β7+ B cells were increased 
in PEDV + VA gilts at PCD 21–29
Gilt MG, spleen, MLN and ileum tissues were analyzed 
for PEDV IgA and IgG ASCs at PCD 21–29. The mean 
numbers of IgA ASCs in spleen and MLN were numeri-
cally higher at PCD 21–29 in mock (± VA) compared 
with PEDV (± VA) gilts (Figure  8A). VA supplemented 
gilts in both mock and PEDV groups had significantly 
higher numbers of mean PEDV IgA ASCs in ileum com-
pared with their respective nonsupplemented treatment 
group (Figure  8A). PEDV IgG ASCs in spleen were sig-
nificantly higher in mock (± VA) compared with PEDV 
(± VA) gilts (Figure 8B). Additionally, mock gilts had sig-
nificantly higher PEDV IgG ASCs in the ileum compared 
to PEDV gilts (Figure 8B). Due to the high mortality rate 
of mock (± VA) litters, MGs of mock gilts regressed rap-
idly [42]. Therefore, there was not enough MG tissue 
available to isolate MNCs and measure PEDV IgA and 
IgG ASCs. Additionally, mean frequencies of ileal α4+β7+ 
B cells were numerically higher in PEDV + VA compared 
with PEDV gilts (Figure 8C).
Discussion
To our knowledge, this is the first study to evaluate the 
effect of VA supplementation on maternal and lactogenic 
immunity during an enteric viral infection in swine. Vita-
min A is a critical mediator of mucosal immune function 
and is essential for lymphocyte trafficking in the gut. For 
example, VAD leads to increased susceptibility to bacte-
rial and viral pathogens and VA supplementation allevi-
ates the negative effects of certain infectious diseases [18, 
27, 29, 43]. This is particularly relevant during pregnancy 
and the neonatal period when there is greater risk for 
clinical and subclinical VAD [44, 45]. To investigate the 
impact of VA on maternal and lactogenic immunity, we 
supplemented third trimester PEDV-infected gilts with 
oral retinyl acetate beginning at GD 76 and throughout 
lactation. We demonstrated that VA supplementation of 
PEDV-infected gilts decreased fecal consistency scores 
in third trimester gilts. Also, PEDV IgA ASCs and Abs, 
IgA IgSCs and  IgA+β7+ B cells in blood and/or milk 
were greater in PEDV + VA gilts coinciding with greater 
mean survival rates in PEDV-challenged nursing piglets. 
Our findings suggest that daily oral VA supplementation 
Figure 6 PEDV antibody (Ab)+ cells in the mammary gland (MG) increased post PEDV challenge. A Evaluation of anti-PEDV  Ab+ plasma cells 
in the MG pre-partum [gestation day (GD) 104–114] and post-partum [post-challenge day (PCD) 5–9] in mock, mock + VA, PEDV and PEDV + VA 
gilts by PEDV viral suspension sandwich immunohistochemistry (IHC) method and hematoxylin staining (300×). Right: enlarged view of MG tissue 
where red arrows indicate PEDV  Ab+ cells. B Cells were quantified by averaging PEDV  Ab+ cells from 3 to 6 microscope fields (300×) from different 
areas of the MG from each animal within mock, mock + VA, PEDV and PEDV + VA gilts. Statistical analysis was performed using the one-way ANOVA. 
***P < 0.001.
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during pregnancy may act as a mucosal adjuvant, enhanc-
ing maternal IgA and lactogenic immunity during PEDV 
infection.
Currently, VA recommendations in swine are 
4000  IU/kg of feed (~7250  IU/day) during gestation 
and 2000  IU/kg of feed (fed ad  libitum) during lac-
tation [31]. However, these recommendations were 
developed assuming disease-free environments. Con-
sidering serum VA concentrations in swine decrease 
with increasing gestation [27] and parity (A.N. Vlasova 
and L.J. Saif, unpublished observations), it is likely that 
dietary VA recommendations for gestating gilts and 
sows are suboptimal during viral or bacterial infec-
tions. Due to the limited available studies on vitamin 
A supplementation in pregnant swine, we relied on 
literature from other species to inform our dose deci-
sion. Females of child-bearing age on a vitamin A-poor 
diet given a single oral dose of 30 000 IU retinyl palmi-
tate produced a dose-related and sustained increase in 
plasma retinyl esters and retinoic acids [46]. Addition-
ally, supplementing pregnant women with an oral dose 
of 10  000  IU/day of vitamin A resulted in enhanced 
Figure 7 Serum IgA antibodies (Abs) in PEDV (± VA) gilts increased to higher levels and at a faster rate than mock (± VA) gilts. A Serum 
PEDV IgA antibody secreting cells (ASCs) and B Ab responses were determined by PEDV ELISPOT and ELISA assay, respectively. C Serum PEDV virus 
neutralizing (VN) Ab responses were determined by VN assay. D Piglet serum circulating PEDV IgA titers were measured by ELISA. Gilts and piglet 
serum was collected at piglet post-challenge day (PCD) 0, 5–9, 12–17 and 21–29. Asterisks indicate significant differences among treatment groups 
at the same time point (mean ± SEM). Statistical analysis was performed using the two-way ANOVA with repeated measures and Bonferroni’s 
correction for multiple comparisons. *P < 0.05 **P < 0.01 ***P < 0.001.
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prenatal H1N1-vaccine responses in mothers [47]. 
Therefore, if viral infection during swine pregnancy 
results in subclinical vitamin A deficiency, we reasoned 
that 30  000  IU would be an appropriate dose to elicit 
a physiological and immunological response. Addition-
ally, based on nonhuman primate data, an oral dose of 
30 000 IU retinoic acid is non-teratogenic [48]. Indeed, 
the presumed upper safe level of dietary VA is up to ten 
times the nutritional requirements in swine [31]. In in a 
previous study, harmful effects of VA toxicity were only 
observed in swine when more than 100 times the nutri-
tional requirement was given over an extended period 
of time [31, 49]. Therefore, we reasoned that daily oral 
VA supplementation of 30 000  IU starting in the third 
trimester and lasting throughout lactation was unlikely 
to cause harmful effects. Indeed, no signs of hypervita-
minosis A [50] were observed in gilts or piglets.
Serum retinol concentrations are homeostatically 
controlled over a range of adequate liver stores [51]; 
therefore it is not surprising that in our study, oral VA 
supplementation did not change serum retinol concen-
trations in gilts. Additionally, the rate of intestinal VA 
metabolism after oral supplementation contributes to the 
systemic exposure to VA metabolites [52]. For example, 
in feed-restricted lactating sows fed 35 µmol of 3,4-dide-
hydroretinyl acetate (vitamin A2), serum 3,4-didehydro-
retinyl ester concentrations peaked 3  h post-prandial 
and returned to near baseline levels by 24 h [53]. If there 
were a transient increase in serum VA concentrations, it 
is unlikely that we would detect it as blood was collected 
from gilts immediately prior to VA supplementation at 
0900 h. Similar to previous findings in swine and humans 
[27, 30], our study demonstrated decreased mean serum 
retinol concentrations immediately prior to parturition. 
This coincides at a time when chemokine CCR9 and 
CCR10 secretion and α4β7+ expression and their cognate 
receptors increase in the MG to recruit circulating ASCs 
into colostrum and milk [54, 55]. These results highlight 
the importance of understanding the role of VA during 
pregnancy and its potential effects on maternal immunity 
and the gut-MG-sIgA during an enteric viral infection.
We observed a lower and faster decline in mean peak 
PEDV RNA shedding titers and significantly decreased 
fecal consistency scores at PID 3 and 5 in PEDV + VA 
compared with PEDV gilts. This suggests that oral VA 
supplementation may enhance innate immune protection 
against PEDV in third trimester gilts. For example, previ-
ous studies of rats [56] and mice [57] reported decreased 
NK cell frequency and function during VAD and sup-
plementation of β-carotene (a VA precursor) in vivo and 
in vitro increased NK cell cytotoxic activity [57]. This is 
in agreement with previous work in our lab demonstrat-
ing an association between increased NK cell frequencies 
in blood and decreased clinical signs in PEDV-challenged 
piglets [58]. PEDV infection is associated with local and 
systemic inflammation and increased concentrations 
of serum innate and proinflammatory cytokines [58, 
59]. Indeed, protection against PEDV-induced disease 
was associated with a delay in serum proinflammatory 
cytokines post PEDV challenge in piglets [58]. Our find-
ings demonstrate a trend whereby PEDV + VA gilts had 
numerically reduced mean proinflammatory cytokines 
and increased immunoregulatory and tissue repair 
cytokines IL-10 and IL-22, respectively, coinciding with 
significantly decreased diarrhea scores compared with 
PEDV gilts. These responses may aide in establishment of 
Figure 8 IgA and IgG antibody secreting cells (ASCs) and α4+β7+ B cells in ileum increased in PEDV + VA gilts. A Mammary gland (MG), 
spleen, mesenteric lymph node (MLN) and ileum mononuclear cells (MNCs) were isolated and added to PEDV ELISPOT plates to determine the 
PEDV specific IgA and B IgG ASCs. C Ileum MNCs were isolated and analyzed for frequencies of α4+β7+ B cells by flow cytometry. Asterisks indicate 
significant differences among treatment groups at the same time point (mean ± SEM). Statistical analysis was performed a two-way ANOVA with 
repeated measures and Bonferroni’s correction for multiple comparisons (A, B) or a Mann–Whitney t-test (C). *P < 0.05 **P < 0.01 ***P < 0.001.
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gut homeostasis, thereby reducing the severity of PEDV 
infection in third trimester gilts.
Oral VA supplementation significantly increased pre-
partum levels of circulating PEDV IgA ASCs,  IgA+β7+ 
MNCs and PEDV IgA Abs post PEDV infection. For 
example, the significant increase in circulating PEDV 
IgA Abs and ASCs at PID 6–8 and 13–17, respectively, 
coinciding with significantly increased normalized 
 IgA+β7+ cells in PEDV + VA gilts, suggests that oral VA 
supplementation increased migration of PEDV stimu-
lated B cells from the intestine into the circulation post 
PEDV infection. Indeed, trafficking IgA ASCs predomi-
nate in the lymphoid tissues of the gut [60] and migrate 
into the circulation after intestinal infection [39]. This is 
in agreement with previous studies from our lab dem-
onstrating an IgA ASC dominant response after intesti-
nal TGEV [61, 62], PEDV [16] and RV [39] infection in 
swine. Our lab also previously demonstrated that VA 
status influences anti-viral B cell immunity. For exam-
ple, HRV-vaccinated VA sufficient piglets had increased 
HRV specific IgA ASCs and Abs in the duodenum post 
HRV challenge compared with vaccinated VAD piglets 
[29]. Furthermore, mucosal associated adhesion recep-
tors are imprinted on immune cells responding to tissue-
specific immune interactions [63]. For example, α4β7 
integrin expression on intestinal lymphocytes increases 
after interaction with VA synthesizing DCs in intestinal 
Peyer’s patches, promoting cellular migration in the gut 
mucosa and lymphoid tissue [24]. In our study, mean 
frequencies of α4+β7+ B cells (normalized to PID 0) 
increased numerically in PEDV (± VA) gilts at PID 6–8 
and 13–17 and mean frequencies of  IgA+β7+ B cells were 
significantly higher at PID 13–17 in PEDV + VA com-
pared with mock and PEDV gilts. This suggests that VA 
supplementation may influence migration of  IgA+ cells 
after PEDV infection.
In our study, PEDV-challenged litters of PEDV + VA 
gilts had a higher survival rate, significantly decreased 
PEDV RNA shedding titers at PCD 2 and a trend for 
lower mean fecal consistency scores at PCD 7–15. The 
increased survival rates in PEDV + VA litters coincided 
with higher frequencies of circulating α4+β7+ B cells at 
PID 6–8 (normalized to PID 0) in gilts and IgA IgSC in 
milk at PPD 8–14 (PCD 5–9). These results are in agree-
ment with previous work in our lab demonstrating that 
increased lactogenic immune protection in PEDV nurs-
ing piglets correlated with PEDV IgA ASCs and Abs in 
milk [16]. Additionally, in TGEV-infected sows, high 
rates of protection are associated with high titers of IgA 
Abs in colostrum and milk [8, 12, 64–66]. Similar find-
ings were also reported in mice where supplementation 
of β-carotene (a proVA metabolite) during pregnancy 
and lactation increased IgA IgSC in the MG during lac-
tation [67, 68]. The significant differences in milk PEDV 
IgA ASCs and total IgA IgSCs in PEDV + VA gilts were 
limited to post piglet PEDV challenge time points, sug-
gesting a role for VA in enhancing anamnestic lactogenic 
immune responses. Future studies investigating the role 
of VA in milk and MG memory B cell function in swine 
are warranted.
While there were no differences in gilt serum immune 
responses between PEDV + VA and PEDV gilts post-
partum, PEDV (± VA) gilt IgA ASCs and IgA and VN 
Abs increased to higher levels and at a faster rate com-
pared with mock (± VA) gilts, suggesting an anamnes-
tic response in PEDV-infected gilts after reexposure to 
PEDV and the naïve status of mock gilts at the time of 
piglet PEDV challenge. Lastly, gilt MG, spleen, MLN 
and ileum tissues were analyzed for PEDV IgA and IgG 
ASCs at PCD 21–29. Due to the high PEDV RNA shed-
ding titers in the feces of mock litters, mock gilts had 
greater exposure to PEDV than PEDV (± VA) infected 
gilts during both primary (pre-partum) or secondary 
exposure (post piglet challenge). Therefore, the num-
bers of mean IgA ASCs in the spleen, MLN and ileum 
and IgG ASCs in the spleen and ileum were higher at 
PCD 21–29 in mock (± VA) compared with PEDV 
(± VA) gilts. Interestingly, however, VA supplemented 
gilts in both mock and PEDV groups had significantly 
higher mean PEDV IgA ASCs in the ileum compared 
with their respective nonsupplemented counterparts. 
Additionally, while not significant, mean frequencies 
of α4+β7+ B cells in ileum were higher in PEDV + VA 
compared with PEDV gilts. These data suggest that 
VA supplementation had an effect on local IgA immu-
nity as demonstrated previously [24, 69] regardless of 
past PEDV exposure, potentiating the levels of traffick-
ing IgA ASCs in serum and the MG. Considering that 
trafficking of  IgA+ plasmablasts to the MG is depend-
ent on CCR10 [70] and that RA influences CCR9 and 
α4β7+-dependent B cell homing in the intestine [23, 
24], future investigation of these molecules and their 
cognate receptor expression and function in VAD mod-
els of swine pregnancy is warranted.
While there are indications that VA regulates mater-
nal Ab responses to mucosal pathogens during preg-
nancy, its potential applications to promote the health 
of neonates remains unexplored. Using a pregnant swine 
model, our data demonstrate that VA supplementation 
in third trimester PEDV-infected gilts have a dual ben-
efit to mother and neonate. VA supplementation resulted 
in less severe diarrhea and lower PEDV RNA shedding 
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titers in pregnant gilts suggesting that VA supplementa-
tion promotes homeostasis and immune regulation in the 
gut post PEDV infection. Additionally, VA supplemented 
gilts had increased anti-PEDV IgA immunity in blood, 
milk and ileum. This was associated with increased sur-
vival rates in PEDV + VA litters post PEDV challenge. 
Based on our innovative approach and results demon-
strating that VA enhanced intestinal immunity during 
pregnancy and lactogenic immune protection in nursing 
piglets, future studies are warranted to better understand 
the mechanisms involved. This model is applicable to 
endemic and emerging enteric viral diseases in humans 
and animals, as similar maternal vaccination and VA sup-
plementation strategies may be needed to enhance the 
gut-MG-sIgA axis and neonatal protection.
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